Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: With the increasing use of GLP-1 receptor agonists (such as Ozempic and Wegovy) for weight loss, the “Ozempic Face” phenomenon has emerged as a growing concern in aesthetic dermatology. This presentation aims to analyze the causes, mechanisms, and clinical presentation of this condition and explore dermatological strategies to manage and prevent facial volume loss associated with rapid weight reduction

Introduction: The “Ozempic Face” phenomenon has emerged as a growing concern in aesthetic dermatology, closely linked to the increasing popularity of GLP-1 receptor agonists such as Ozempic and Wegovy for weight loss. First highlighted in popular media, the term refers to the facial volume loss and accelerated aging appearance observed in individuals undergoing rapid weight reduction with these blockbuster drugs.

Materials / method: A retrospective observational analysis was conducted on patients undergoing GLP-1-induced weight loss who sought dermatological consultation for facial volume loss. Clinical data were collected on:

Rate of weight loss and its correlation with the severity of facial aging.
Skin elasticity and volume loss assessment using standardized dermatological grading scales.
Interventions performed, including dermal fillers, biostimulatory agents, fat grafting, and skin tightening procedures.
Patient satisfaction scores post-treatment.

Results: A direct correlation was observed between the speed of weight loss and the severity of Ozempic Face. Patients who lost weight too rapidly exhibited more significant fat atrophy and sagging.
Hyaluronic acid fillers and biostimulatory injectables (Sculptra, Radiesse) effectively restored volume with high patient satisfaction.
Skin tightening procedures (radiofrequency, ultrasound, and lasers) improved skin texture and elasticity.
Preventive strategies, such as slower weight loss approaches and early dermatological intervention, were recommended to minimize aesthetic side effects.

Conclusion: The Ozempic Face phenomenon represents a new challenge in aesthetic dermatology. Dermatologists should adopt a preventive and corrective approach, ensuring that weight loss occurs at a controlled pace to minimize excessive facial volume depletion. Multimodal interventions, including injectable fillers, energy-based treatments, and fat grafting, provide effective solutions to restore facial harmony. As the demand for GLP-1-based weight loss treatments continues to rise, dermatologists must be prepared to manage the aesthetic implications while guiding patients through a healthy and sustainable

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Describe DWAT, the dynamic of fat tissues and it's role in regeneration and rejuvenation treatment

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: The aim is to provide the audience with tools on the different techniques to resolve the reduction or atrophy of facial fat. The what, when and why of the chosen techniques will be explored. The results of each of the described techniques will be shown.

Introduction: There are different causes that generate central facial fatty atrophy. Some are congenital, such as Binder's syndrome, and others are acquired, such as the consumption of antiretrovirals. This condition affects our patients emotionally and they consult us for a solution. In addition to the causes described above, we must also consider aesthetic causes, where the patient, even if it is not an extreme case, wishes to improve the appearance of the middle third of the face.

Materials / method: Patients treated by me using synthetic injectables, fat fillers and using 3 different types of facial implants.

Results: They will be shown during my presentation.

Conclusion: The middle third of the face is a high-impact area when considering the facial appearance of any individual. It is key to improve it when there is a deficit of fatty tissue, and for that it is important to know all the therapeutic options to achieve it.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability